Header cover image

Indonesian (IDX) Pharma Industry Analysis

UpdatedMay 18, 2024
DataAggregated Company Financials
Companies8
  • 7D4.6%
  • 3M-8.7%
  • 1Y-28.3%
  • YTD-17.8%

The Pharma industry is up 1.8% in the last week, with Kalbe Farma up 5.6%. In contrast, the industry has lost 26% in the last 12 months. Earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 18 May 2024Rp91.6tRp67.7tRp4.4t12.8x20.8x1.4x
Mon, 15 Apr 2024Rp92.9tRp66.6tRp4.4t14x21.2x1.4x
Wed, 13 Mar 2024Rp90.2tRp65.9tRp4.7t18.6x19x1.4x
Fri, 09 Feb 2024Rp93.7tRp65.9tRp4.7t17.2x19.8x1.4x
Sun, 07 Jan 2024Rp100.2tRp65.9tRp4.7t18.3x21.1x1.5x
Tue, 05 Dec 2023Rp100.8tRp65.8tRp5.2t21.3x19.2x1.5x
Thu, 02 Nov 2023Rp101.6tRp65.8tRp5.4t19.2x18.8x1.5x
Sat, 30 Sep 2023Rp106.2tRp65.6tRp5.4t22.2x19.7x1.6x
Mon, 28 Aug 2023Rp108.0tRp65.6tRp5.4t21.1x20x1.6x
Wed, 26 Jul 2023Rp115.5tRp64.2tRp5.3t21.6x21.7x1.8x
Fri, 23 Jun 2023Rp118.8tRp64.2tRp5.3t21x22.3x1.8x
Sun, 21 May 2023Rp123.4tRp64.2tRp5.3t21.5x23.2x1.9x
Tue, 18 Apr 2023Rp119.7tRp64.1tRp4.7t19.1x25.6x1.9x
Thu, 16 Mar 2023Rp121.8tRp65.0tRp4.6t20.3x26.3x1.9x
Sat, 11 Feb 2023Rp136.3tRp65.0tRp4.6t21x29.5x2.1x
Mon, 09 Jan 2023Rp122.7tRp65.0tRp4.6t21.9x26.5x1.9x
Wed, 07 Dec 2022Rp122.7tRp64.9tRp4.3t27.8x28.2x1.9x
Fri, 04 Nov 2022Rp120.8tRp64.8tRp4.6t15.8x26x1.9x
Sun, 02 Oct 2022Rp115.0tRp67.1tRp5.1t19.9x22.5x1.7x
Tue, 30 Aug 2022Rp107.0tRp67.0tRp5.1t17.6x21.1x1.6x
Thu, 28 Jul 2022Rp110.1tRp66.7tRp5.2t15.1x21.1x1.7x
Sat, 25 Jun 2022Rp110.2tRp66.7tRp5.2t14.4x21.1x1.7x
Mon, 23 May 2022Rp108.2tRp66.2tRp5.2t20.7x20.6x1.6x
Wed, 20 Apr 2022Rp107.6tRp64.6tRp5.3t23.2x20.2x1.7x
Fri, 18 Mar 2022Rp112.1tRp63.2tRp5.1t25x21.9x1.8x
Sun, 13 Feb 2022Rp116.8tRp63.2tRp5.1t24.7x22.8x1.8x
Tue, 11 Jan 2022Rp123.6tRp63.2tRp5.1t24.6x24.1x2x
Thu, 09 Dec 2021Rp117.3tRp61.6tRp4.9t25x24x1.9x
Sat, 06 Nov 2021Rp116.9tRp60.0tRp4.4t25.5x26.4x1.9x
Mon, 04 Oct 2021Rp104.4tRp58.5tRp4.3t21.8x24.4x1.8x
Wed, 01 Sep 2021Rp103.2tRp57.5tRp4.3t21.6x24.3x1.8x
Thu, 08 Jul 2021Rp111.3tRp57.5tRp4.3t18.9x26.2x1.9x
Price to Earnings Ratio

26x


Total Market Cap: Rp107.9tTotal Earnings: Rp4.1tTotal Revenue: Rp56.1tTotal Market Cap vs Earnings and Revenue0%0%0%
Indonesian Pharma Industry Price to Earnings3Y Average 22.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Indonesian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.5x which is lower than its 3-year average PE of 22.9x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 2.1% per year over the last three years.
  • Revenues for these companies have grown 6.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indonesian Healthcare industry?

ID Market4.21%
Healthcare1.43%
Pharma4.58%
Pharma4.58%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KLBF Kalbe FarmaRp1.50k5.6%
+Rp3.7t		-30.9%PE24.2x
PYFA Pyridam FarmaRp104.003.0%
+Rp1.1t		-86.0%PS1.7x
TSPC Tempo Scan PacificRp2.06k3.5%
+Rp315.7b		40.1%PE9.1x
INAF IndofarmaRp246.0050.9%
+Rp257.2b		-62.2%PS1.1x
KAEF Kimia FarmaRp725.001.4%
+Rp55.7b		-8.8%PS0.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PYFA

Rp104.00

Pyridam Farma

7D

3.0%

1Y

-86.0%

KAEF

Rp725.00

Kimia Farma

7D

1.4%

1Y

-8.8%

PEHA

Rp484.00

Phapros

7D

-1.6%

1Y

-30.4%

DVLA

Rp1,500.00

Darya-Varia Laboratoria

7D

1.0%

1Y

-22.7%

KLBF

Rp1,500.00

Kalbe Farma

7D

5.6%

1Y

-30.9%

TSPC

Rp2,060.00

Tempo Scan Pacific

7D

3.5%

1Y

40.1%

SOHO

Rp500.00

Soho Global Health

7D

0.4%

1Y

-3.8%

INAF

Rp246.00

Indofarma

7D

50.9%

1Y

-62.2%